Translated title of the contribution | Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. |
---|---|
Original language | Undefined/Unknown |
Pages (from-to) | 2183-2189 |
Number of pages | 7 |
Journal | Blood |
Volume | 109 |
Issue number | 5 |
Publication status | Published - 2007 |
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
C. Bossard, K. Belhadj, F. Reyes, N. Martin-Garcia, F. Berger, J.A. Kummer, J. Brière, A-C. Baglin, S. Cheze, J. Bosq, V. Ribrag, C. Gisselbrecht, N. Mounier, P. Gaulard
Research output: Contribution to journal › Article › Academic › peer-review